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ABSTRACT
Homing endonucleases (HEs) cut long DNA target
sites with high specificity to initiate and target the
lateral transfer of mobile introns or inteins. This high
site specificity of HEs makes them attractive
reagents for gene targeting to promote DNA modi-
fication or repair. We have generated several hun-
dred catalytically active, monomerized versions
of the well-characterized homodimeric I-CreI and
I-MsoI LAGLIDADG family homing endonuclease
(LHE) proteins. Representative monomerized I-CreI
and I-MsoI proteins (collectively termed mCreIs or
mMsoIs) were characterized in detail by using a
combination of biochemical, biophysical and struc-
tural approaches. We also demonstrated that both
mCreI and mMsoI proteins can promote cleavage-
dependent recombination in human cells. The use of
single chain LHEs should simplify gene modification
and targeting by requiring the expression of a single
small protein in cells, rather than the coordinate
expression of two separate protein coding genes
as is required when using engineered heterodimeric
zinc finger or homing endonuclease proteins.
INTRODUCTION
Genome engineering requires the ability to direct bio-
chemical activities (such as single- or double-strand clea-
vage, recombination or integration) to target sites with a
high degree of site and/or sequence speciﬁcity. Several dif-
ferent types of genome engineering reagents are being
developed to target speciﬁc genes. Among the best devel-
oped of these highly sequence-speciﬁc reagents are homing
endonuclease (HE) proteins. The HEs consist of several
families of nucleases that catalyze the lateral transfer
(or ‘homing’) of parasitic DNA elements in all kingdoms
of life (1). HEs are most often encoded as open reading
frames (ORFs) in mobile introns or inteins. They catalyze
and target the lateral transfer of their coding intron or
intein by cleaving homologous alleles that lack the
intron or intein sequence to initiate recombination depen-
dent repair oﬀ the intron-/intein-containing allele (2).
The DNA target or ‘homing’ sites for HEs consist of
long (14–40bp) sequences that are recognized and cleaved
with high speciﬁcity in vitro and in vivo. Despite their high
site speciﬁcity, many HEs can tolerate at least some target
site base pair changes without the loss of site binding or
cleavage speciﬁcity (3,4). The ability to maintain high site
speciﬁcity while tolerating limited target site sequence
divergence may represent an evolutionarily advantageous
strategy for many HEs by maximizing the opportu-
nities for continued mobility while minimizing oﬀ-target,
cleavage-dependent toxicity.
We have focused on engineering novel variants of the
largest and best characterized of the ﬁve HE families, the
LAGLIDADG HEs (LHEs). These proteins were identi-
ﬁed, as were other homing endonuclease families, on the
basis of several consistent features: location within mobile
or optional intervening sequences as ORFs; the presence
of conserved short sequence motifs within their coding
sequences; similar DNA target or homing site lengths of
18–24bp; and similar mechanisms of DNA recognition
and catalysis. LHEs all contain two copies of a conserved
abbabba core fold that includes a single ‘LAGLIDADG’
motif (1). This motif contributes several residues to the
intersubunit or interdomain interface as well as a C-term-
inal acidic acid residue to the LHE active site (4–9). LHE
active sites are located directly at the center of the protein
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binding surfaces (comprised of antiparallel b-sheets from
each protein domain). LHE proteins containing a single
LAGLIDADG motif per peptide chain, such as I-CreI
and I-MsoI, function as homodimers that cleave pseudo-
palindromic DNA target sites. In contrast, LHEs with two
LAGLIDADG motifs per protein chain, such as I-SceI
and I-AniI, are pseudo-symmetric monomers that are
able to recognize asymmetric DNA target sites.
The modular architecture of LAGLIDADG proteins
suggested that DNA cleavage should be tightly coupled
to target site recognition, and that it should be possible to
redesign site recognition speciﬁcity without disrupting cat-
alytic eﬃciency. This hypothesis has been veriﬁed by
experiments demonstrating the separation of site binding
and cleavage activities of homodimeric I-CreI (10–15) and
I-MsoI (16), as well as for the monomeric I-SceI (17) and
PI-SceI (18) LHE proteins. Several novel chimeric
LHEs have also been generated by taking advantage of
the modular structure of LHEs: an I-CreI monomer has
been fused with one domain of the thermophilic LHE
I-DmoI (19) to generate H-DreI (11,20), and a portion
of the DNA recognition region of monomeric PI-SceI
has been successfully substituted with a DNA recogni-
tion module from the Candida tropicalis VMA1
LAGLIDADG intein (21).
Monomeric LHEs are the most appropriate starting
point for creating gene targeting reagents because they
are not constrained to recognize symmetric DNA target
sites. However, the homodimeric LHE proteins have thus
far proven more amenable to high resolution crystallo-
graphic analyses (1,4) and have been used for design and
selection experiments as well as for in vivo targeted gene
modiﬁcation or correction (10–16). In vivo applications
have most recently employed two diﬀerent LHE variants
that form obligate heterodimers when coexpressed in cells
(22). However, this latter strategy involves the delivery
and coordinated expression of two proteins, and thus
may be diﬃcult or problematic to implement.
In this article, we report the generation of hundreds of
catalytically active, single-chain variants of the well-
characterized homodimeric LHEs I-CreI and I-MsoI.
We refer to these monomerized I-CreI and I-MsoI pro-
teins below as mCreI and mMsoI variants. These new
monomeric LHE proteins were generated by inserting a
randomized polypeptide linker library between two diver-
gent copies of the I-CreI or I-MsoI ORF, followed by
in vivo selection in Escherichia coli for catalytic activity
at 308C. Furthermore, the characterization of several
mCreI and mMsoI proteins demonstrated site-speciﬁc
DNA-binding aﬃnities and cleavage activities similar to
their homodimeric precursors I-CreI and I-MsoI. A high-
resolution co-crystal structure of one mMso variant with
a 33 residue linker revealed a canonical LHE structural
fold with partial ordering of the linker adjacent to the
now-linked I-MsoI subunit C- and N-termini. We also
demonstrated that both mCre and mMso proteins were
catalytically active in human cells and able to pro-
mote cleavage-dependent recombination to generate
green ﬂuorescent protein-positive (GFP+) cells. These
well-characterized single-chain LHEs should facilitate
the engineering of mCre or mMso variants with the ability
to target and cleave asymmetric DNA target site
sequences in vivo.
MATERIALS AND METHODS
Plasmids, bacterial and chemicals
The bacterial selection plasmids pEndo and pCcdB were
generous gifts from David Liu (Harvard University) (17).
The bacterial protein expression plasmids pET15b and
pET24d, and the E. coli host strain NovaXGF0 used for
in vivo selection and protein expression were obtained
from Novagen (Gibbstown, NJ). Other reagents, includ-
ing restriction enzymes, Taq DNA polymerase and ligase,
were obtained from New England Biolabs (Ipswich, MA)
or from Sigma-Aldrich (St Louis, MO).
Construction ofmonomeric homingendonuclease libraries
Pairs of ORF cassettes encoding native I-CreI or I-MsoI
proteins were designed in which codon usage was opti-
mized for expression in E. coli and between which nucleo-
tide sequence divergence was maximized without changing
coding properties. These divergent ORF pairs, synthesized
by Blue Heron (Bothell, WA), were then cloned into
pENDO separated by a short linker oligonucleotide con-
taining AgeI, SpeI and KpnI cleavage sites to create linker
recipient expression vectors for monomeric I-CreI or
I-MsoI (pENDOmCre and pENDOmMso, respectively;
Figure 1). A previously described random linker library,
kindly provided by Michelle Scalley-Kim and David






The resulting linkers were cleaved with AgeI and KpnI,
and then ligated into AgeI/KpnI-cleaved pENDOmCre
and pENDOmMso to generate linker insert libraries of
monomeric I-CreI and I-MsoI proteins for in vivo selec-
tion. The target site plasmids used for in vivo selection,
pCcdB-Crewt2 and pCcdB-Msowt2, each contained
single copies of the native I-CreI or I-MsoI recognition
site inserted at the pCcdB Nhe I/Sac II and Aﬂ III/Bgl
II cloning sites (Figure 1).
Invivo selection ofactive monomeric homing endonucleases
Catalytically active mCreI and mMsoI homing endonu-
cleases were selected from linker insert libraries by two
rounds of positive selection in a CcdB in vivo selection
system (17). In brief, pENDO coding plasmid libraries
were transformed into bacterial containing either a
pCcdBCrewt2 or a pCcdBMsowt2 target site plasmid, fol-
lowed by selection for survival and colony formation on
plates containing 0.02% arabinose and 0.2mM IPTG.
Colonies formed after growth for 3 days at 308C were
streaked onto plates containing carbenicillin, or carbeni-
cillin and chloramphenicol in order to identify bacterial
that retained the pENDO coding plasmid and either lost
Nucleic Acids Research,2009, Vol.37, No. 5 1651or retained the pCcdB selection plasmid. Plasmid DNA
from clones surviving on carbenicillin alone was puriﬁed
and retransformed into bacteria containing either
pCcdBCrewt2 or pCcdBMsowt2 for a second round of
selection in order to conﬁrm that survival was pENDO
plasmid-dependent.
Proteinexpression andpurification
The mCreI and mMsoI ORFs from plasmids that had
undergone two rounds of in vivo selection were sequenced
and then subcloned into the NcoI/NotI sites of pET15b
and pET24d (Novagen) prior to transformation into
E. coli strain C2566 (New England Biolabs). Overnight
cultures of single colonies were grown at 308C, inoculated
into fresh LB media containing carbenicillin or kanamycin
and then grown to A600=0.8at 378C prior to inducing
protein expression by the addition of 1mM IPTG fol-
lowed by growth for 3h at 378C. Proteins expressed
from pET15b had N-terminal 6  His tags, and were
puriﬁed using Ni-NTA agarose resin (Qiagen) according
to the manufacturer’s protocol. For crystallographic ana-
lyses, proteins expressed from pET24d were puriﬁed as
previously described (4).
Invitro cleavage assays
pCcdB target vectors containing single copies of the native
I-CreI or I-MsoI target site were linearized by AatII diges-
tion for cleavage assays. Cleavage reactions contained
200ng of linearized pCcdB plasmid DNA and diﬀerent
amounts of puriﬁed mCre or mMso protein in 20mlo f
20mM Tris pH 8.0, 10mM MgCl2 buﬀer. Reactions
were incubated at 378C for 1h, stopped by the addition
of loading buﬀer containing 0.1% SDS, and the digestion
products were separated by agarose gel electrophoresis.
Circulardichroism (CD) analysis
Far UV CD spectra (250–190nm) were recorded at 208C
on a Jasco J-815 chiro-optical spectrometer equipped with
a PFD-425 Peltier thermoelectric temperature controller.
Protein samples (5mM) in PBS were analyzed in a 0.1cm
path length quartz cuvette (Hellma) to acquire continuous
(1nm band width) spectra with an 8s response time and
scan speed of 10nm/min. Five scans were compiled to
generate ﬁnal spectra for each sample. Thermal denatura-
tion curves were obtained at a protein concentration of
10 mM. Ellipticity at 222nm was recorded at 18C/min
intervals over a temperature range of 10–958C. The
mean residue ellipticity [] was calculated from the equa-
tion: []=8 MRW/10l c where [] is the mean residue
ellipticity in degrees/cm
2/decimole, 8 the measured ellip-
ticity angle in millidegrees at wavelength , MRW is the
mean residue weight, l is the optical path length of the
cell in centimeters and c is the protein concentration in
milligrams per milliliter (24). The percentage of a-helix
in secondary structure was estimated using the equation:
fraction of a-helix=(–[]222 nm+3000)/39000 (25).
Isothermal titration calorimetry (ITC)
ITC experiments were performed on a VP-ITC
MicroCalorimeter (MicroCal LLC) following the
manufacturer’s protocol using protein samples that had
been dialyzed overnight against 50mM Tris pH 8.0,
75mM NaCl and 10mM CaCl2. Protein samples
(3–5mM) were placed in the ITC cell and target site
DNA’s (40–50mM) in the auto-pipette injector.
Individual experiments consisted of 25–35 injections of
5–9ml of target site DNA (depending on sample concen-
tration) at 308C with a constant stirring speed of
300r.p.m. Data were curve ﬁt using Origin 7 SR2 ITP
analytical software (OriginLab Corporation).
In vivorecombination assays
Mammalian expression vectors for mCreI and mMsoI
were constructed by cloning Cre or Mso ORF’s into the
mammalian transient expression vector pCS2nlsMT
where ORF expression is driven by a CMV promoter.
Target plasmids for in vivo cleavage were modiﬁed from
pDR-GFP (26) to replace the original I-SceI cleavage site
with a single copy of the native I-CreI or I-MsoI cleavage
site. Transient transfections were performed using 293T
cells in 24-well plates. Cells were grown in Dulbecco-
modiﬁed Eagle’s medium (Cellgro) supplemented with
10% fetal bovine serum (Cellgro) and 1% penicillin/strep-
tomycin (Gibco) at 378C in a humidiﬁed 5% CO2 incuba-
tor. Cells were plated 24h prior to transfection at 3 10
5
cells per well in 500ml of complete growth medium, corre-
sponding to 50–80% conﬂuency at the time of transfec-
tion. A modiﬁed calcium phosphate protocol (27) was
used to transfect cells with 1.5mg per well of expression
plus reporter DNA in a 3:1 molar ratio of expression to
target plasmid DNA.
Transfected cells were analyzed for GFP ﬂuorescence
48h after transfection. Cells were tryspinized and
washed in PBS, resuspended at  10
6 cells/ml and then
stained in PBS containing 10ng/ml propidium iodide
prior to analysis on an Inﬂux ﬂow cytometer (Cytopeia).
Typically 40000 events were scored and gated for log
side vs. linear forward scatter and for PI exclusion to iden-
tify viable single cells for GFP ﬂuorescence analysis. The
fraction of cells transfected in each experiment was esti-
mated by determining the frequency of GFP+ cells that
had been transfected with the positive control vector
pEGFP-C1 (Clontech).
Crystallization, data collection and structural refinement
Co-crystals of mMsoI:DNA were grown using 4mg/ml
mMsoI protein and a 2-fold molar excess of I-MsoI
target site DNA. The target site DNA (50-GCAGAACG
TCGTGAGACCGTTCCG-30) was generated by anneal-
ing the oligonucleotide shown with a complementary
24mer at 188C in 24–30% PEG 400, 100mM Tris pH
8.0, 10mM CaCl2, 50mM NaCl as previously described
(4). Data were collected in-house using an RAXIS-IV ima-
ging plate area detector (Rigaku, USA), and a rotating
anode X-ray generator with a copper source that provided
X-rays at 1.54A ˚ wavelength. The resulting data were
reduced using DENZO and SCALEPACK, and the struc-
ture was solved by molecular replacement using Phaser
with the original I-MsoI:DNA structure as an initial
search model. The resulting structure was modeled using
1652 Nucleic Acids Research, 2009, Vol. 37,No. 5Wincoot (http://www.ysbl.york.ac.uk/ lohkamp/coot/),
and reﬁned to 2.7A ˚ resolution using Refmac (http://mac.
softpedia.com/get/Math-Scientiﬁc/refmac.shtml) with 5%
of the data excluded for cross-validation. The crystal para-
meters and structural reﬁnement statistics are summarized
in Table 3.
RESULTS
mCreI and mMsoI library construction
Our previous co-crystal structures of I-CreI and I-MsoI
demonstrated that the C- and N-termini of adjacent sub-
units were separated by a substantial distance,  70A ˚ , that
would need to be bridged with a polypeptide linker to
generate monomeric versions of either protein (4). One
previous eﬀort to generate a monomeric version of
I-CreI used an 11 amino-acid linker from the I-DmoI
LAGLIDADG HE to connect intact and partially deleted
I-CreI subunits. The resulting protein was soluble, though
displayed reduced activity and thermal stability (11).
In order to generate better-behaved, monomeric versions
of I-CreI and I-MsoI we used longer linkers to join sub-
unit C- and N-termini and to avoid truncating either pro-
tein subunit. This experimental strategy is shown in
Figure 1.
We knew from previous structural analyses that long
linkers were present in some LHE proteins (e.g. the 18
residue linker in I-AniI) (9). We were also inspired by
experiments, which demonstrated that peptide linkers ran-
ging from 30 to 120 amino-acid residues could be tolerated
in the loop region of an SH2 domain without disrupting
structure or binding in a phage surface display-based SH2
domain ligand-binding assay (23). These experiments
demonstrated that linker insertions could be tolerated in
a folded host protein without destabilizing local structure
or function, and provided a library of partially rando-
mized, experimentally veriﬁed linkers for our experiments
(Figure 1).
Complex libraries of monomeric I-CreI and I-MsoI sub-
units were generated in two steps. First, we synthesized
two diﬀerent genes encoding the I-CreI or I-MsoI ORFs
and cloned these into an expression vector separated by a
short multiple cloning site to generate a ‘linker recipient’
expression vector for each protein. The ORFs were codon
optimized for expression in E. coli, and designed to min-
imize nucleotide sequence identity between the tandem
I-CreI or I-MsoI coding sequences without changing the
encoded protein sequences. This was done to minimize
deletions or other homology-mediated rearrangements
between the directly repeated I-CreI or I-MsoI coding
sequences. Libraries of polypeptide linkers (previously cre-
ated in selection experiments to identify well-tolerated
loop insertion elements) (23) were then inserted into
each linker recipient expression vector to generate libraries
of I-CreI or I-MsoI ORFs in which the two protein sub-
units were joined by polypeptide linkers of varying length
and amino acid composition (Figure 1).
The complexities of the resulting mCreI or mMsoI
libraries were both  1 10
6 (results not shown). DNA
sequence analysis of randomly chosen clones from the
unselected libraries identiﬁed linkers ranging from 13 to
93 residues. We also identiﬁed several ‘linkerless’ clones in
each unselected library in which the two protein subunits
were joined by six residues encoded by our multiple clon-
ing site (Figure 1). The predominant linker lengths in both
selected libraries were 13 and 33 residues, corresponding
to the two most prevalent lengths present in our unselected
libraries (Supplementary Figure 1). Thus, a majority of
linkers in both unselected and selected libraries were
 33 residues, or long enough to bridge the  70A ˚ distance
between the N- and C-termini of I-CreI and I-MsoI.
All linker-containing clones in unselected libraries
shared two common ﬂanking polypeptides: TGSGSGS
at linker N-termini and GSGSGSGT at linker C-termini.
These Gly-Ser repeats were incorporated during construc-
tion of the original loop library to provide ﬂexible regions
ﬂanking linkers in order to minimize disruption of well-
ordered domains or folds following linker insertion (23).
The N- and C-terminal Thr-Gly (AgeI) and Gly-Thr
(KpnI) termini provided additional ﬂexibility for further
manipulation or linker transfer. The 20 residue periodicity
Figure 1. Generation and characterization of catalytically active, mono-
meric versions of I-CreI and I-MsoI. Two divergent copies of the I-CreI
or I-MsoI ORF were synthesized, and cloned into expression vectors
together with an intervening multiple cloning site linker. A library of
previously generated, randomized linkers was then PCR-ampliﬁed,
cleaved and inserted at the multiple cloning site to generate libraries
of monomeric mCre and mMso proteins with linker insertions. Active
monomeric proteins were identiﬁed on the basis of an activity-
dependent selection in E. coli, then characterized by a combination of
biochemical, biophysical and functional assays. A high resolution
co-crystal structure was also generated for one of the mMsoI proteins
with a 33 residue linker (see Figure 5).
Nucleic Acids Research,2009, Vol.37, No. 5 1653observed in longer linkers (Supplementary Figure 1 and
Table 1) reﬂected the use of randomized 18 residue blocks
separated by a Gly-Ser pair encoded by a BamHI site to
construct the original loop library (23).
The deduced amino-acid sequences of linkers from both
libraries contained all 20 amino acids (Supplementary
Figure 1). This was surprising as cysteine was originally
excluded from linker sequences to limit entropic costs
resulting from intra-loop disulﬁde bond formation. The
presence of small numbers of cysteines likely reﬂects muta-
tions generated during library construction, propagation
or PCR to transfer the linker library into mCreI and
mMsoI (23). Small and/or polar amino acid residues
such as Thr, Gly, Ala, Ser and Asn were among the
most common residues in linker sequences. Large aro-
matic residues such as Phe, Trp and Tyr, in contrast,
were the least common.
Invivo selection ofactive, monomericHEs
We used an in vivo, E. coli-based selection protocol to
identify catalytically active single-chain HEs in both of
our libraries. This method was a modiﬁcation of the selec-
tion system originally developed by Liu and colleagues
(17). In outline, a low copy number plasmid was used to
express mCreI or mMsoI under control of an arabinose-
regulatable pBAD promoter. A second, high copy-number
target plasmid consisted of HE cleavage sites ﬂanking
a LacZ-ccdB gene fusion gene encoding the CcdB
(controlled cell death protein B) E. coli DNA gyrase inhib-
itor protein that could be induced with IPTG (Figure 1).
Cell viability in this system depends on HE cleavage and
elimination of the pCcdB plasmid encoding the toxic
LacZa-ccdB protein (17).
In minimal media at 308C, expression of native homo-
dimeric I-CreI and I-MsoI rescued almost 100% of cells
harboring a pCcdB plasmid DNA carrying two copies of
the I-CreI or I-MsoI target site (Table 1). In contrast,
expression of catalytically inactive forms of either protein
(D20N I-CreI or D22N I-MsoI) under the same selection
conditions led to a  10
4-fold reduction in survival to
fewer than 1 in 10
4 cells plated (Table 1). Similar low
surviving fractions were observed when catalytically
active I-CreI or I-MsoI were expressed in cells containing
pCcdB plasmids with non-cognate HE target sites
(Table 1). These results indicated that this activity-based
selection was robust, activity-dependent and suﬃciently
sensitive to discriminate between the I-CreI and I-MsoI
target sites that diﬀered at only two base pair positions.
Two rounds of positive selection of our mCreI and
mMsoI libraries yielded several hundred linker insert-
positive plasmids from each library (results not shown).
We randomly selected and sequenced the mCre ORF
from 141 randomly selected mCreI or mMsoI clones
(Supplementary Table 1), and further characterized the
19 diﬀerent mCreI and 13 diﬀerent mMsoI variants.
Sequencing revealed single ORFs in selected variants in
which I-CreI or I-MsoI subunits were separated by linkers
ranging from 13 to 53 residues (mMsoI) or from 13 to 73
residues (mCreI; Supplementary Table 1). The most
common linker length in each library was 33 residues
(Supplementary Table 1 and Supplementary Figure 1).
The amino acid composition of linkers in mCreI and
mMsoI proteins selected on the basis of activity resembled
the residue distribution observed in unselected libraries
with two exceptions: a  2-fold drop in the abundance of
glycine residues, and variable increases in residues with
bulky (phenylalanine, histidine, proline, tryptophan and
tyrosine) or negatively charged (arginine, lysine) side
chains (Supplementary Figure 1). No additional sequence
conservation was observed when linker sequences were
aligned for either family of monomerized proteins
(Supplementary Table 1; additional results not shown).
Biochemical characterization ofmCreI and mMsoI
The biochemical characterizations of sequence-veriﬁed
mCreI and mMsoI proteins were begun by examining
in vitro cleavage of a linearized plasmid DNA substrate
containing a single copy of the native I-CreI or the I-MsoI
target site. All 19 mCreI proteins and all 13 mMsoI pro-
teins demonstrated in vitro cleavage activity in these
assays. We characterized the activity of 13 mCreI proteins
and 8 mMsoI proteins in more detail as shown in Figure 2
and Supplementary Table 1. All 21 puriﬁed proteins
showed in vitro cleavage activities comparable to their
homodimeric counterparts (I-CreI or I-MsoI), with
mCreI slightly less active than homodimeric I-CreI
(Figure 2a). mMsoI, in contrast, appeared as active as
homodimeric I-MsoI (Figure 2b). There was no detectable
diﬀerence in cleavage activity as a function of protein
linker length for mCreI variants with 13–73 residue linkers
or for mMsoI variants with 13–53 residue linkers of
variable composition. These results indicate that many
diﬀerent linker lengths and compositions are compatible
with in vitro cleavage activity. We focused our subsequent
analyses on the most straightforward and potentially
useful of the monomeric mCreI and mMsoI proteins
having linker lengths of 33 residues.
One concern in both selection and cleavage assays was
the potential of mCreI and mMsoI proteins to form active
endonucleases as dimeric or higher order oligomers. We
used physical and activity-based assays to address this
issue. First, size exclusion chromatography demonstrated
that both mCreI and mMsoI eluted at volumes similar to
homodimeric native I-CreI or I-MsoI (Figure 2c). Both
monomeric proteins and their homodimeric precursors
Table 1. In vivo selection results for speciﬁc endonuclease–target site
pairs
Protein Target site Survival
a (%)
I-CreI I-CreI native 97.8 19.6
I-CreI D20N I-CreI native (8.8 1.4) 10
–3
I-MsoI I-CreI native (1.1 0.1) 10
–3
I-MsoI I-MsoI native 98.6 4.3
I-MsoI D22N I-MsoI native (7.9 1.4) 10
–3
I-CreI I-MsoI native (1.7 0.4) 10
–3
aSurvival rates were calculated by the number of colonies grown on
selective media over the total number of cells plated. Survival for each
endonuclease–target site pair were calculated from determinations per-
formed in triplicate.
1654 Nucleic Acids Research, 2009, Vol. 37,No. 5when expressed in E. coli also had elution volumes that
were similar to a 44kDa chicken ovalbumin protein size
standard (Figure 2d), in good agreement with the pre-
dicted molecular weights for I-CreI (37.4kDa), mCreI
(40.4kDa), I-MsoI (38.9kDa) and mMsoI (43kDa).
Corresponding western blot data indicated that all four
proteins were of predicted molecular weight after transient
expression in human cells (see below).
We also constructed and determined the catalytic activ-
ities of mCreI and mMsoI variants with single inactivating
substitutions in one half of their active sites (D20N mCreI
and D22N mMsoI). Prior structural and biochemical
analyses of I-CreI (4,28) and I-MsoI (28) predicted that
these single active site mCreI or mMsoI proteins should be
catalytically inactive unless mCreI or mMsoI dimers or
higher order oligomers were the active form of either
endonuclease. D22N mMsoI did retain detectable strand
nicking activity. However, neither D20N mCreI nor
D22N mMsoI protein had detectable DNA double
strand cleavage activity at protein concentrations up to
1.6mM (data not shown).
Biophysical characterization of mCreI and mMsoI
In order to determine whether linker insertion aﬀected the
stability or binding aﬃnity of either mCreI or mMsoI, we
expressed and puriﬁed to homogeneity mCreI and mMsoI
proteins with 33 residue linkers as previously described
(4), and then analyzed each protein by far-UV CD analy-
sis and ITC.
The far-UV CD analysis was performed to assess over-
all structural features of mCreI and mMsoI as compared
with their homodimeric counterparts I-CreI and I-MsoI
(Figure 3, top panels). The far-UV CD spectra of mCreI
and mMsoI were very similar to their homodimeric coun-
terparts and characteristic of proteins with mixed a/b
Figure 2. In vitro cleavage and puriﬁcation of monomeric and native, homodimeric versions of I-CreI and I-MsoI. (a, b) In vitro cleavage analyses
using a linearized plasmid DNA substrate revealed comparable cleavage activities of monomeric and homodimeric versions of I-CreI and I-MsoI.
Nineteen additional monomeric variants were characterized in similar fashion (Supplementary Table 1). Protein concentrations were 12.5–3200mM
for the I-CreI/mCreI proteins and 50–6400nM for I-MsoI/mMsoI proteins. (c) Elution proﬁles of I-MsoI (blue) and mMsoI (red) were super-
imposable in size exclusion chromatography analyses on a HiLoad 16/60 Superdex 75 column (GE healthcare, Piscataway, NJ). Gel ﬁltration
analysis of all four proteins revealed predicted molecular weights when compared with an equivalent size gel ﬁltration standard (MW
std=44kDa chicken ovalbumin; Biorad, Hercules, CA).
Nucleic Acids Research,2009, Vol.37, No. 5 1655topology and estimated a-helical contents of 58% and
46%, respectively. Homodimeric I-CreI and I-MsoI had
CD spectra characteristic of proteins with mixed a/b
topology, and had estimated a-helical contents of 67%
and 58%, respectively. The values for monomeric and
homodimeric protein pairs were virtually identical when
diﬀerences in polypeptide chain lengths were normalized.
This indicates that most of the linker regions in mCreI
and mMsoI lack deﬁned secondary structure. Thermal
denaturation proﬁles were remarkably similar as were
midpoint transition temperatures for homodimeric and
monomeric I-CreI (Tm values of 66.88C and 64.68C,
respectively), and for I-MsoI and mMsoI (Tm values of
54.38C and 56.28C, respectively; Figure 3, bottom panels).
These results indicate that linker insertion did not disrupt
the structure or stability of either monomeric protein, or
promote the formation of potentially confounding dimer
or higher order oligomers.
The binding of I-CreI, mCreI, I-MsoI and mMsoI to
their cognate DNA target sites was analyzed by ITC.
The thermodynamic parameters and proﬁles for each
HE:DNA target site pair are shown in Figure 4, and
summarized in Table 2. Homodimeric and monomeric
protein pairs showed similar two-phase endothermic
binding isotherms. The measured dissociation constants
(KD) for I-CreI and I-MsoI were, as predicted, close to
half the values determined for mCreI and mMsoI
(13.3nM/22.3nM for I-CreI/mCreI, and 21.0nM/
40.2nM for I-MsoI/mMsoI). This diﬀerence reﬂects the
molar stoichiometry of protein–DNA interactions that
were  2:1 for I-CreI and I-MsoI, and  1:1 for mCreI
and mMsoI. These results indicate that mCreI and
mMsoI have native DNA target site binding aﬃnities
that are similar to their homodimeric counterparts. This
is also reﬂected in calculated free energies (Gbinding),
enthalpic changes (H) and entropic changes (–TS)
for protein–DNA interactions that were found, again, to
be virtually identical for each homodimer/monomer pro-
tein pair (Table 2).
Co-crystal structure of mMsoI
We determined the structure of mMsoI bound to its
native DNA target site to provide additional insight into
the structure of a monomerized LHE protein. This
mMsoI:DNA substrate complex was crystallized in the
presence of calcium ions under conditions previously
described (4), and the structure was determined at 2.7A ˚
resolution (Figure 5 and Table 3). The mMsoI:DNA com-
plex contained, as predicted, an intact 24bp DNA target
site that crystallized in space group P1 with one complex
per unit cell, i.e. the same as previously observed for a
homodimeric I-MsoI:DNA complex (4). The overall struc-
tures of mMsoI:DNA and I-MsoI:DNA were highly
Figure 3. Far-ultraviolet CD and thermal denaturation proﬁles of homodimeric and monomeric I-CreI (a) and I-MsoI (b). All four curves in both
CD and thermal denaturation analyses were generated by best ﬁt analyses for a two-state transition, and had 50% transition temperatures of 66.8
(I-CreI), 64.6 (mCreI), 54.3 (I-MsoI) and 56.28C (mMsoI), respectively.
1656 Nucleic Acids Research, 2009, Vol. 37,No. 5super-imposable, with an overall RMSD of 0.47A ˚ except
for the linker region (Figure 5a). Substrate DNA bending
was also very similar in the I-MsoI:DNA and
mMsoI:DNA structures, including a signiﬁcant distortion
of the central  1bp region of target site DNA that is
thought to facilitate cleavage (Supplementary Figure 2).
We were particularly interested in determining what
portion of the mMsoI linker could be visualized in this
Figure 4. DNA binding and thermodynamic proﬁles for homodimeric and monomeric I-CreI and I-MsoI as determined by ITC. Heat absorption
upon the injection of native target site DNAs can be seen in upper panels in (a) for I-CreI/mCreI and in (b) for I-MsoI and mMsoI. The molar ratio
of injected target site DNA to protein is shown in bottom panels. Results for all proteins could be ﬁtted to standard saturation curves, and all four
proteins displayed endothermic binding proﬁles. A summary of thermodynamic parameters for all four proteins is given in Table 3. Panel (b) I-MsoI
data were adapted from ref. 32.
Nucleic Acids Research,2009, Vol.37, No. 5 1657structure, and whether this led to any signiﬁcant distortion
of the I-MsoI core fold adjacent to the linker insertion
points. In the original cocrystal structure of the I-MsoI
bound to substrate DNA, the ﬁrst ﬁve N-terminal and
last four C-terminal residues in each domain were not vis-
ible due to structural ﬂexibility (4). In the mMsoI:DNA
structure, composite omit mapping analyses allowed us to
model 12 additional amino-acid residues: eight linker resi-
dues at the C-terminus of the Mso1 domain, and two
linker residues at the N-terminus of the Mso2 domain.
The remainder of the linker region in mMsoI is disordered
and could not be visualized. These results are in good
agreement with our biophysical characterization of
mMsoI.
The active sites in both complexes were superimposable,
containing two bound calcium ions as determined by
anomalous diﬀerence mapping (Figure 5b). The discrep-
ancy in number of calcium ions between the previously
reported I-MsoI:DNA structure (4) and our
mMsoI:DNA structures reﬂects the use of diﬀerent meth-
ods to identify diﬀerent metal ions during structure reﬁne-
ment. During the original I-MsoI structure determination,
the binding of calcium was modeled based on a 2Fo – Fc
diﬀerence Fourier analysis (4) which is not as deﬁnitive as
the anomalous diﬀerence mapping we used to model cal-
cium binding in the mMsoI structure. We can only visu-
alize calcium and manganese (not magnesium) with
anomalous diﬀerences. The use of this method indicated
two bound calciums in uncleaved complexes with that
metal, and three bound manganese ions in cleaved com-
plexes formed with manganese. With magnesium in any of
these structures, the best we can do is 2Fo – Fc diﬀerence
mapping that indicates three bound metals. Thus, the
most recent structural and biochemical data are consistent
with the active forms of both I-MsoI/mMsoI and I-CreI/
mCreI having three magnesium ions bound coordinately
between two active sites, and sharing a common catalytic
mechanism.
In vivoactivity in human cells
In order to determine whether monomeric I-CreI
and I-MsoI were catalytically active in human cells,
we co-transfected two plasmids into cells that encod-
ing an endonuclease protein and a corresponding
Figure 5. Superposition of the I-MsoI:DNA and newly determined mMsoI:DNA co-crystal structures. (a) side and top views of the native homo-
dimeric I-MsoI and newly determined monomeric mCreI co-crystal structures reveals backbone superposition with a 0.47A ˚ RMSD for protein and
DNA. I-MsoI and mMsoI structures, and their DNA molecules, are shown respectively in cyan, yellow, purple and pink. Three calcium ions in
I-MsoI:DNA structure and two calcium ions in mMsoI:DNA structure are shown, respectively, in green and coral. (b) Superposition of the I-MsoI
and mMsoI active sites. Three active site residues—D22, Q50 and K104—with two calcium ions and two nucleotides ﬂanking the scissile phospho-
diester bond are shown. Four water molecules from I-MsoI:DNA and mMsoI:DNA structures are shown as small spheres in grey or tan, respec-
tively. Anomalous diﬀerence mapping analysis revealed two calcium ions in the mMsoI:DNA active site. Figures were prepared using the CCP4
Molecular Graphics software package (33).
Table 2. Aﬃnities and thermodynamic values for homing endonu-
clease–DNA binding








I-CreI 13.3 2.6 19.6 0.20 101 1.2 –30.6 –11.0
MCreI 22.3 1.7 21.0 0.12 104 1.0 –31.5 –10.5
I-MsoI
a 21.0 5.0 12.7 0.27 77 1.1 –23.3 –10.6
MMsoI 40.2 9.6 14.7 0.4 82.4 1.0 –25.0 –10.3
aAdapted from ref. (32).
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plasmid. Site-speciﬁc cleavage of the reporter plasmid
by the HE protein in vivo promotes homology-dependent
gene conversion of the reporter plasmid to generate
GFP+ cells that can be detected and quantiﬁed by
ﬂow cytometry (Figure 6a). Human 293T cells were used
for these experiments as they are recombination-
proﬁcient and can be transiently transfected at very high
(95–100%) eﬃciency. This assay can be performed rapidly
with diﬀerent combinations and amounts of input DNA,
and thus allowed the rapid, quantitative functional char-
acterization of mCreI, mMsoI and diﬀerent versions of
homodimeric I-CreI or I-MsoI in human cells.
Cells that were mock-transfected, or transfected with
circular DR-GFPCre or DR-GFPMso recombination
reporter plasmids had low autoﬂuorescence or back-
ground recombination frequencies (0.1% autoﬂuorescence
vs. 2.0–3.9% of reporter-only transfected cells; Figure 6b).
I-CreI and I-MsoI coding plasmids strongly induced the
GFP+ cell fraction when transfected with a cognate
reporter plasmid (GFP+ frequencies were 33.2% for
I-CreI, and 10.7% for I-MsoI in experiments shown in
Figure 6b). Comparable frequencies of GFP+ cells were
seen following the co-transfection of a DR-GFPCre repor-
ter plasmid with either an mCreI-coding or an
I-CreI-coding plasmid (29.8% vs. 33.2%; Figure 6b). In
contrast, mMsoI was more eﬃcient at inducing GFP+
cells than was I-MsoI (19.5% vs. 10.7%; Figure 6b).
GFP+ frequencies in these assays provide a reliable
estimate of the in vivo activity of speciﬁc homing endonu-
clease proteins. This is indicated by the high transfection
eﬃciency ( 95%) in all experiments, the ability of in vitro
XhoI-linearized DR-GFP reporter plasmids to consis-
tently generate  25–30% GFP+ cells and the inability
of catalytically inactive D20N I-CreI or D22N I-MsoI
when co-transfected with reporter plasmid to induce
GFP+ cells above background (Figure 6c). Western
blot analyses indicated that all endonuclease proteins
were expressed at comparable levels in these experiments,
and were of predicted molecular weight for homodimeric
or monomeric Cre or Mso variants (results not shown).
Thus, these experiments demonstrate that mCreI and
mMsoI proteins are catalytically active in vivo, and can
eﬃciently promote site-speciﬁc, cleavage-dependent
recombination to generate GFP+ cells.
DISCUSSION
We generated monomeric versions of the well-character-
ized and experimentally tractable homodimeric LHE
proteins I-CreI and I-MsoI to further facilitate the engi-
neering of LHEs to cleave asymmetric DNA target sites in
living cells. Targeted gene modiﬁcation or repair has relied
thus far on engineered zinc ﬁnger nucleases (ZFNs)
or homodimeric LHEs that are formed from pairs of
co-expressed proteins. The in vivo use of either ZFNs or
homodimeric LHEs obligatorily requires the coordinate
expression of pairs of proteins in target cells. This strategy,
as initially employed led to the formation of mixtures
ZFN or LHE homo- and heterodimers that had variable
degrees of in vivo site-speciﬁc activity or activity-depen-
dent toxicity. More recent eﬀorts have focused on the
design of ZFN or LHE protein pairs that preferentially
form heterodimers in solution as a way to ameliorate these
problems (22,29).
The identiﬁcation of native, monomeric LHEs having
asymmetric DNA target sites provided us with the moti-
vation and rationale to generate new, monomeric LHEs
from pre-existing, homodimeric LHEs. We focused on
two well-characterized, biochemically tractable LHEs,
I-CreI and I-MsoI. These LHEs share partially degenerate
palindromic sequences that diﬀer by 1 base pair in each
DNA half-site (4). Our previously determined a high-
resolution co-crystal structures for each protein revealed
nearly superimposable conserved abbabba core folds,
though substantially diﬀerent b-sheet DNA–protein inter-
faces and contact maps that might facilitate engineering
toward speciﬁc asymmetric DNA target sites.
We successfully generated libraries of several hundred
active monomerized I-CreI and I-MsoI proteins (mCreIs
and mMsoIs) by inserting random polypeptide linkers to
join two LHE subunits into single ORFs. Characterization
of selected examples from the mCreI and mMsoI protein
libraries showed that both types of protein were of full
length when expressed in E. coli or in human cells, were
well-ordered and biochemically as well as biophysically
well-behaved in vitro and catalytically active in human
cells. Our experimental approach may also be useful for
generating other novel proteins from pre-existing domains
or subunits, especially if there is a facile selection or screen
available to identify the desired novel fusion protein
product(s).
The experimental approach we used may reﬂect the evo-
lutionary history of LHEs. One model for LHE evolution
Table 3. Summary of data processing and reﬁnement statistics for
mMsoI co-crystal structure determination
Parameter mMsoI result/value
Space group P1
















RMSD bond length (A ˚ ) 0.008
RMSD angle (8) 1.110




Average B (A ˚ 2) (protein, DNA) 59.2
aOuter resolution bin 2.76–2.69.
Nucleic Acids Research,2009, Vol.37, No. 5 1659begins with a small, ancestral monomeric protein precur-
sor that formed ﬁrst a functional homodimer that after
gene duplication, fusion and domain divergence gave
rise to present day monomeric LHEs (30). The ability to
eﬃciently recognize asymmetric DNA target sites would
be greatly enhanced by subunit fusion, and would provide
a substantially broader range of potential DNA target
sites and hosts to ensure evolutionary persistence. Target
site diversiﬁcation after fusion may have been facilitated in
this model by pre-existing target site asymmetry in the
ancestral homodimer fusion partners. This type of asym-
metry exists, as shown by our recent structural analyses of
the I-CeuI LHE. This structurally symmetric, homodi-
meric LHE was able to recognize asymmetric DNA
target site base pairs in each half site by using diﬀerent
side chain rotamer torsion angles and bridging water net-
works (31).
The availability of well-characterized mCreI and
mMsoI LHEs should further facilitate the engineering of
protein variants to cleave asymmetric DNA target sites
Figure 6. mCreI and mMsoI induce catalytic activity-dependent recombination in human cells. (a) In vivo recombination activity was assayed by
co-transfecting coding plasmids for I-CreI or I-MsoI proteins together with a recombination reporter plasmid that contains a direct repeat of two
genetically inactive copies of GFP. In vivo cleavage of the I-CreI or I-MsoI target site initiates gene conversion and repair of the cleaved copy to
generate GFP+ cells that can be detected and quantiﬁed by ﬂow cytometry (Materials and methods section). (b) Flow histograms of cells mock-
transfected, transfected with reporter plasmid alone, or co-transfected with reporter: endonuclease plasmid pairs. The gate for GFP+ cells is shown
by the boxed area, and the GFP+ frequency is given in the lower right of each histogram. (c) Frequency and fold increase in GFP+ cells for
diﬀerent reporter/coding plasmid combination. The frequency of GFP+ cells generated by in vitro XhoI-linearized DR-GFPCre reporter DNA (
 )
indicates that a substantial fraction of reporter molecules are likely cleaved in vivo by I-CreI and mCreI. D20N I-CreI and D22N I-MsoI are
catalytically inactive mutants of I-CreI and I-MsoI which fail to induce GFP+ cells when cotransfected with a Cre or Mso-speciﬁc reporter plasmid.
Error bars are means   SDs.
1660 Nucleic Acids Research, 2009, Vol. 37,No. 5in vivo. The ability to develop gene- or genomic region-
speciﬁc LHE variants may be further facilitated by having
starting pairs of well-characterized monomeric proteins
that use substantially diﬀerent sets of DNA–protein con-
tacts to recognize and bind closely related DNA target
sites. The use of engineered versions of mCreI or mMsoI
would be simpler than for either ZFNs or homodimeric
LHEs as expression of a single protein, rather than
co-ordinate expression of two diﬀerent proteins, would
be required in target cells. A ﬁnal advantage of using
LHE-derived genome engineering reagents is the inher-
ently tight coupling of site binding to cleavage among
LHE proteins. This desirable property ensures high site
speciﬁcity and activity, while minimizing oﬀ-target cleav-
age events. Thus engineered target site-speciﬁc versions
of mCreI, mMsoI or other well-documented LHEs
should aid in vivo analyses of gene structure and function,
as well as targeted, gene-speciﬁc modiﬁcation or repair
for purposes of disease therapy or prevention.
COORDINATE SUBMISSION
The structure and X-ray structure factor amplitudes of
mMsoI bound to its DNA target site in the presence of
calcium has been submitted to the RCSB database (PDB
ID code 3FD2).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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